SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Mobileye first quarter revenue falls by almost 50% as clients cut back on spending to clear excess stock

Melio names Boaz BenDavid as its first Chief Financial Officer

Check Point registers higher than expected Q1 profit helped by growth of AI-powered security platform

Microsoft explains how Generative AI impacts IP law and compliance

Buzz

Most popular

Daily

Weekly

1

Nvidia announces $700 million acquisition of Run:ai

2

Nvidia on verge of completing $700 million acquisition of Run:ai

3

Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale

4

Nvidia continues Israel shopping spree with acquisition of Deci

5

Nagomi Security raises $23 million Series A for proactive defense platform

Drugs

20 stories about Drugs

מפגש עיתונאים ראשון עם נשיא ומנכל חברת טבע ריצ'רד פרנסיס

Why are Teva shares surging and how does it plan to keep it up

04.04.24|Uri Tel Tenne

Since the beginning of the year, Teva's shares have risen by about 36%, and are among the best performing stocks on the Tel Aviv Stock Exchange. Why is this happening and how is the company's CEO planning to build on the momentum?

קור שולץ מנכ"ל טבע 9.11.19

The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO

19.02.20|Sophie Shulman

Teva’s stock fluctuation is not the result of wrongdoing regarding the U.S. opioid abuse epidemic, but rather something born of the creativity of lawyers, Kåre Schultz said Wednesday at the company’s annual press conference in Tel Aviv

לקוחה מתנסה ב מחשב ש מעניק אינפורמציה על תרופות ללא מרשם רפואי

Over-the-Counter Drug Prices in Israel are Much Higher Than Overseas

17.02.20|Orna Yefet

The Israeli Ministries of Health and Economy summoned OTC drug manufacturers and distributors for meetings after a study found prices are 37% higher on average in Israel

מוסף תרופה תרופות בית מרקחת

Teva Israel to Stop Distribution of Weight Loss Drug Amid Cancer Concerns

16.02.20|Lilach Baumer

On Thursday, the manufacturer of Belviq weight loss drug, Eisai, announced it was withdrawing the drug from the U.S. market after a five-year trial found it increased risk of cancer by 0.6%

קור שולץ מנכ"ל טבע 9.11.19

Teva’s Small Print Gives Rise to Optimism

13.02.20|Sophie Shulman

The improvement CEO Kåre Shultz promised is not immediately evident in the drugmaker’s forecast for 2020, but a closer look shows Teva’s new brand drugs are starting to live up to their promise

קור שולץ מנכ"ל טבע 9.11.19

Teva Fights Muddy Reputation With Positive Report

23.01.20|Sophie Shulman

Calcalist obtained a report commissioned by the Israeli drugmaker that details its economic contribution to the countries in which it operates

זריקה חיסון רופא מוסף

Fat Melting Startup Raziel Therapeutics Raises $22 Million

19.12.19|Adi Pick

The company's drug is injected into subcutaneous fat where it causes immediate fat cell death at the injection site, resulting in a reduction of fat tissue

מטה חברת טבע תרופות

Teva in Talks With U.S. DoJ to End Price-Fixing Probe, Report Says

The Israeli drugmaker, along with several other companies investigated in the matter, have been holding talks on the subject for the past six months, Bloomberg reported

אתר טבע כפר סבא

Teva’s Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing

17.11.19|Navit Zomer

The Israeli drugmaker’s manufacturing facility in Kfar Saba, already experienced with manufacturing cash cow Copaxone, will oversee the process of filling the syringes with the biological drug and also conduct quality control tests

מוסף תרופה תרופות בית מרקחת

RedHill Receives FDA Approval for H. Pylori Gastric Drug

05.11.19|Tzally Greenberg

H. pylori is a type of drug-resistant gastric bacteria linked with increased risks of developing ulcers and stomach cancer

מטה חברת טבע תרופות

Teva Overcomes One Hurdle, Many Still Ahead

23.10.19|Hezi Sternlicht

The Israeli drugmaker announced on Monday two major achievements regarding the opioid abuse lawsuits against it; but even without taking into consideration its additional legal complications, the settlements it has reached will severely strain its resources

מטה חברת טבע תרופות

Teva Part of $50 Billion Opioid Settlement Deal, Report Says

17.10.19|Hezi Sternlicht

Teva, a second drugmaker, and the three largest drug distributors in the U.S. have agreed with multiple states on a settlement framework ahead of Monday’s trial, the New York Times reported Thursday

אתר טבע כפר סבא

Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says

16.10.19|Hezi Sternlicht

The Israeli drugmaker and several other drug distributors are set to face around 2,500 lawsuits related to the U.S. opioid abuse epidemic in just a week at a Cleveland, Ohio federal court

חברת תרופות אלרגן

Allergan Says Teva Bears Sole Liability for Actavis' Actions

02.09.19|Hezi Sternlicht

Actavis, which Teva bought from Allergan in 2016 for $40.5 billion, was one of the top U.S. sellers of opioids in 2006-2012

אתר טבע כפר סבא

Teva Faces New Opioid-Related Lawsuit in West Virginia

25.08.19|Hezi Sternlicht

The lawsuit seems to be unrelated to the trial set to start against Teva and other opioid manufacturers in October in Ohio federal court

יוסי משי טלגראס

Telegrass' Marijuana Operation: Method, Testimonies, and Question Marks

10.07.19|Amir Kurz

On March 12, Israel Police arrested 42 people suspected of holding top management positions in Israeli drug distribution network Telegrass, which operated via encrypted instant messaging app Telegram

מטה חברת טבע תרופות

Teva Reaches $85 Million Settlement in Oklahoma Opioid Damages Suit

27.05.19|Hezi Sternlicht

Teva is one of several opioid manufacturers being sued in the U.S. by different states and private entities for its alleged role in the nation's opioid addiction crisis

מטה חברת טבע תרופות

This Is how Teva and 19 of its Rivals Fixed U.S. Drug Prices

15.05.19|Hezi Sternlicht, Ran Abramson, and Tomer Ganon

A 524-page civil lawsuit filed Friday in the U.S. alleges that 20 generic drugmakers colluded to influence drug prices, with executives meeting regularly to set prices and split the market

קרית שמונה קריית שמונה

Teva Completes $47.5 Million Sale of Northern Israeli Plant to Private Equity Fund FIMI

02.05.19|Hezi Sternlicht

Teva is selling the plant following its 2017 plan to ameliorate its crippling debt by divesting non-core businesses and closing or selling many of its manufacturing plants

עומרי שור מדיסייף

Medisafe Partners with American Healthcare Consulting Firm Lash

30.04.19|Meir Orbach

Lash will combine Medisafe's mobile drug compliance application into its current service programs, to help patients adhere to their drug-taking regimen